 Effect chronic treatment glucocorticoid antagonist RU man toxicity immunological hormonal aspects Suppression immune function pharmacological levels glucocorticoids recent studies rodents glucocorticoids tonic antiinflammatory/immunosuppressive effects basal nonstress concentrations basal glucocorticoid secretion modulates immune function man specific glucocorticoid receptor antagonist RU tonic level inhibition immune system basal glucocorticoid levels present potentiation enhancement immune function absence glucocorticoid action hypothesis healthy male normal volunteers RU mg/kg.day placebo vehicle daily oral doses days Blood samples days measurement plasma ACTH cortisol concentrations urine samples measurement free cortisol excretion Complete differential blood counts erythrocyte sedimentation rates C-reactive protein antinuclear antibodies rheumatoid factor quantitative immunoglobulins intervals Leukocytes leukopheresis phenotypic characterization functional analysis days initiation RU placebo therapy Blockade cortisol receptors RU marked compensatory elevations plasma ACTH cortisol increases urinary excretion free cortisol subjects days RU treatment subject symptoms signs consistent diagnosis adrenal insufficiency Total white blood cell counts absolute lymphocyte neutrophil eosinophil counts erythrocyte sedimentation rate quantitative immunoglobulins RU therapy T- B- natural killer cell subsets RU treatment Furthermore functional evaluation lymphocyte cytotoxicity proliferation changes administration high doses RU normal volunteers measurable enhancement immune function man glucocorticoids tonic inhibitory effect immune system rodents compensatory increase endogenous cortisol effect glucocorticoid antagonist immune system ABSTRACT TRUNCATED AT WORDS